CCL2 and neoplasm: Pro-inflammatory cytokines secreted by tumor cells or stromal cells, such as interleukin 6 (IL6), IL1β and C-C motif chemokine ligand 2 (CCL2), can induce phenotypic changes in tumor cells, recruit bone marrow-derived cells and form an inflammatory environment.